aquaresis

aquaresis

the excretion of solute-free water.
References in periodicals archive ?
These rapid-onset agents promote an aquaresis with normalization of serum [Na+] in a controlled manner without neurological injury in clinical conditions similar to EAH.
Aquaresis with arginine vasopressin (AVP) antagonists is showing promise, he said.
Vaprisol is the first AVP receptor antagonist with a demonstrated safety profile and that effectively promotes aquaresis in order to help restore salt and water balance in patients with euvolemic and hypervolemic hyponatremia.
In contrast to diuretics, tolvaptan is designed to promote the excretion of electrolyte-free water, known as aquaresis.
VAPRISOL is the first AVP receptor antagonist with a demonstrated safety profile and that effectively promotes aquaresis which helps to restore salt and water balance in patients with euvolemic and hypervolemic hyponatremia.
In a randomized, double-blind, placebo-controlled study, intravenous administration of Vaprisol 40 mg/day for four days achieved a clinically meaningful aquaresis which resulted in increased serum sodium levels in hospitalized patients with hypervolemic hyponatremia.
VAPRISOL is the first AVP antagonist that safely and effectively promotes aquaresis for improved management of salt and water imbalance in hospitalized patients with euvolemic hyponatremia.